Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Identification of putative genetic modifying factors that influence the development of Papillon-Lefévre or Haim-Munk syndrome phenotypes.

Tytuł:
Identification of putative genetic modifying factors that influence the development of Papillon-Lefévre or Haim-Munk syndrome phenotypes.
Autorzy:
Pap ÉM; Department of Obstetrics and Gynecology Szeged, University of Szeged, Szeged, Hungary.
Farkas K; Department of Medical Genetics, University of Szeged, Szeged, Hungary.
Tóth L; Department of Medical Genetics, University of Szeged, Szeged, Hungary.
Fábos B; Mór Kaposi Teaching Hospital, Kaposvár, Hungary.
Széll M; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
Németh G; Department of Obstetrics and Gynecology Szeged, University of Szeged, Szeged, Hungary.
Nagy N; Department of Medical Genetics, University of Szeged, Szeged, Hungary.; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Jul; Vol. 45 (5), pp. 555-559. Date of Electronic Publication: 2020 Mar 09.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2023- : Oxford : Oxford University Press
Original Publication: Oxford : Blackwell Scientific Publications.
MeSH Terms:
Mutation, Missense*
Phenotype*
Acro-Osteolysis/*genetics
Cathepsin C/*genetics
Papillon-Lefevre Disease/*genetics
DNA Mutational Analysis ; Female ; Humans ; Male ; Polymorphism, Single Nucleotide ; Signal Transduction
References:
Nagy N, Vályi P, Zs Csoma et al. CTSC and Papillon-Lefèvre syndrome: detection of recurrent mutations in Hungarian patients, a review of published variants and database update. Mol Gen Genom Med 2014; 2: 217-28.
Selvaraju V, Markandaya M, Prasad PV et al. Mutation analysis of the cathepsin C gene in Indian families with Papillon-Lefèvre syndrome. BMC Med Genet 2003; 4: 5.
Dalgic B, Bukulmez A, Sari S. Eponym: Papillon-Lefevre syndrome. Eur J Pediatr 2011; 170: 689-91.
Gorlin RJ, Sedano H, Anderson VE. The syndrome of palmar-plantar hyperkeratosis and premature periodontal destruction of the teeth: a clinical and genetic analysis of the Papillon-Lefèvre syndrome. J Pediatr 1964; 65: 895-908.
Haneke E. The Papillon-Lefèvre syndrome: keratosis palmoplantaris with periodontopathy: report of a case and review of the cases in the literature. Hum Genet 1979; 51: 1-35.
Haim S, Munk J. Keratosis palmo-plantaris congenita, with periodontosis, arachnodactyly and a peculiar deformity of the terminal phalanges. Br J Dermatol 1965; 77: 42-54.
Hart TC, Hart PS, Bowden DW et al. Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome. J Med Genet 1999; 36: 881-7.
Papillon PH, Lefèvre P. Deux cas de kératodermie palmaire et plantaire symétrique familiale (Maladie de Meleda) chez le frère et la soeur. Coexistence dans les deux cas d’altérations dentaires graves. Bull Soc Fr Dermatol Syphiligr 1924; 31: 82-7.
Hewitt C, McCormick D, Linden G et al. The role of cathepsin C in Papillon-Lefèvre syndrome, prepubertal periodontitis, and aggressive periodontitis. Hum Mutat 2004; 23: 222-8.
Adkison AM, Raptis SZ, Kelley DG et al. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 2002; 109: 363-71.
Toomes C, James J, Wood AJ et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999; 23: 421-4.
Sulák A, Tóth L, Farkas K et al. One mutation, two phenotypes: a single nonsense mutation of the CTSC gene causes two clinically distinct phenotypes. Clin Exp Dermatol 2016; 41: 190-5.
Machado RA, Cuadra-Zelaya FJM, Martelli-Júnior H et al. Clinical and molecular analysis in Papillon-Lefèvre syndrome. Am J Med Genet A 2019; 179: 2124-31.
Jarinova O, Ekker M. Regulatory variations in the era of next-generation sequencing: implications for clinical molecular diagnostics. Hum Mutat 2012; 33: 1021-30.
Kiritsi D, Valari M, Fortugno P et al. Whole-exome sequencing in patients with ichthyosis reveals modifiers associated with increased IgE levels and allergic sensitizations. J Allergy Clin Immunol 2015; 135: 280-3.
Lapinski PE, Oliver JA, Kamen LA et al. Genetic analysis of SH2D4A, a novel adapter protein related to T cell-specific adapter and adapter protein in lymphocytes of unknown function, reveals a redundant function in T cells. J Immunol 2008; 181: 2019-27.
Hamilton G, Colbert JD, Schuettelkopf AW et al. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J 2008; 27: 499-508.
Lacazette E, Gachon AM, Pitiot G. A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the oral and genital spheres. Hum Mol Genet 2000; 9: 289-301.
Schaefer AS, Richter GM, Nothnagel M et al. A genome-wide association study identifies GLT6D1 as a susceptibility locus for periodontitis. Hum Mol Genet 2010; 19: 553-62.
Tomassini Barbarossa I, Ozdener MH, Love-Gregory L et al. Variant in a common odorant-binding protein gene is associated with bitter sensitivity in people. Behav Brain Res 2017; 329: 200-4.
Tcatchoff L, Nespoulous C, Pernollet JC et al. A single lysyl residue defines the binding specificity of a human odorant-binding protein for aldehydes. FEBS Lett 2006; 580: 2102-8.
Lee DS, Park J, Kay KA et al. The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA 2008; 105: 9880-5.
Grant Information:
EFOP-3.6.1-16-2016-00008 Emberi Erőforrás Fejlesztési Operatív Program; GINOP-2.3.2-15-2016-00039 Gazdaságfejlesztési ls Innovációs Operatív Program
Substance Nomenclature:
EC 3.4.14.1 (CTSC protein, human)
EC 3.4.14.1 (Cathepsin C)
SCR Disease Name:
Keratosis palmoplantaris with periodontopathia and onychogryposis
Entry Date(s):
Date Created: 20200112 Date Completed: 20200706 Latest Revision: 20200706
Update Code:
20240105
DOI:
10.1111/ced.14171
PMID:
31925812
Czasopismo naukowe
Background: Papillon-Lefévre syndrome (PLS; OMIM 245000) and Haim-Munk syndrome (HMS; OMIM 245010), which are both characterized by palmoplantar hyperkeratosis and periodontitis, are phenotypic variants of the same disease caused by mutations of the cathepsin C (CTSC) gene.
Aim: To identify putative genetic modifying factors responsible for the differential development of the PLS or HMS phenotypes, we investigated two Hungarian patients with different phenotypic variants (PLS and HMS) but carrying the same homozygous nonsense CTSC mutation (c.748C/T; p.Arg250X).
Methods: To gain insights into phenotype-modifying associations, whole exome sequencing (WES) was performed for both patients, and the results were compared to identify potentially relevant genetic modifying factors.
Results: WES revealed two putative phenotype-modifying variants: (i) a missense mutation (rs34608771) of the SH2 domain containing 4A (SH2D4A) gene encoding an adaptor protein involved in intracellular signalling of cystatin F, a known inhibitor of the cathepsin protein, and (ii) a missense variant (rs55695858) of the odorant binding protein 2A (OBP2A) gene, influencing the function of the cathepsin protein through the glycosyltransferase 6 domain containing 1 (GLT6D1) protein.
Conclusion: Our study contributes to the accumulating evidence supporting the clinical importance of phenotype-modifying genetic factors, which have high potential to aid the elucidation of genotype-phenotype correlations and disease prognosis.
(© 2020 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies